Rabbit Polyclonal RNF125 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human RNF125 aa 100-200.
View Alternative Names
E3 ubiquitin-protein ligase RNF125, RING finger protein 125, T-cell RING activation protein 1, TRAC-1, RNF125
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RNF125 antibody (AB211450)
Immunohistochemical analysis of formalin fixed, paraffin embedded Human small intestine tissue labeling RNF125 with ab211450 at 5ug/mL.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RNF125 antibody (AB211450)
Immunohistochemical analysis of formalin fixed, paraffin embedded Human thymus tissue labeling RNF125 with ab211450 at 5μg/mL.
- WB
Supplier Data
Western blot - Anti-RNF125 antibody (AB211450)
All lanes:
Western blot - Anti-RNF125 antibody (ab211450) at 1/500 dilution
Lane 1:
K562 cell extract
Lane 2:
HT29 cell extract
Lane 3:
K562 cell extract with synthesized RNF125 peptide
Predicted band size: 26 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RNF125 participates in the immune response by modulating the activity and stability of key signaling proteins. It forms part of a regulatory complex that influences immune signaling pathways. RNF125 acts by ubiquitinating proteins like MAVS which play a role in antiviral responses. Through ubiquitination RNF125 helps regulate the balance between activation and suppression of immune reactions ensuring proper immune function.
Pathways
Researchers have identified RNF125 as an important component of the type I interferon signaling pathway and the TLR (Toll-like receptor) pathway. In the type I interferon pathway RNF125 targets proteins such as MAVS and RIG-I playing a role in antiviral defense. Furthermore RNF125 interacts with TRAF6 in the TLR pathway influencing the body's innate immunity and inflammation responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Microorganisms 12: PubMed39065185
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 297:101190 PubMed34517008
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 35:109272 PubMed34161773
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com